Navigation Links
The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
Date:12/8/2011

JERUSALEM, December 8, 2011 /PRNewswire/ --

The Joint Management Authority of the European Neighbourhood and Partnership Instrument (ENPI CBC MED program) has informed Prof Nava Ben Zvi, President of Hadassah College in Israel that they will award a contract of up to 2 million Euro for the Bio-Xplore Project. This project, initiated and directed by Hadassah College, will be implemented in partnership with the Biodiversity and Environmental Research Center of the Palestinian Authority, Leitat Technological Center in Spain, and the Hellenic Regional Development Center in Greece. Two US-based Universities Rutgers University, New Jersey and the North Carolina State University, will also participate in the project.

Prof Bertold Fridlender, Director of Hadassah College's Biotechnology Department is the inspiration and driving force behind the BioXplore project. He explained: "the goal of the project is to identify endemic plants from the Mediterranean area, which contain compounds that may be valuable for industrial products such as pharmaceutical products, food additives, cosmetics and others. This collaborative research will promote social and financial developments in the Mediterranean Sea Basin Area."

As part of the Bio-Xplore project, a Mediterranean branch of the Global Institute for Bio-Exploration (GIBEX-MED) will be created. The GIBEX (http://www.gibex.org) centers are active today in Africa, America and Asia, and aim to initiate and support international joint research and development. These joint activities promote the development of biological products based on natural resources endemic to each of the partnering countries. The products are focused on achieving health and environmental targets in developing countries.  

Prof Nava Ben Zvi, President of Hadassah College, Jerusalem stated: "This program will enable collaboration on an academic level with industrial and business potential for each of the involved partners".

The project will be part of the curriculum of the Biotechnology Department in Hadassah College. The Department was founded to prepare students for joining the industrial workforce and continuing post graduate studies and research. According to Prof Fridlender: "The conditions, the knowledge and the minds in Israel today are an outstanding base for this project and we are confident in its success."  

Link to the program website:

http://www.enpicbcmed.eu/documenti/29_153_20111028122848.pdf

For more information: Yaniv Rosenberg, PR Hadassah College +972-50-4488962, yaniv@rcspr.co.il; Dan Shoshani, PR +972-523608508



'/>"/>
SOURCE Hadassah College
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
2. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
3. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
4. ApoA-I Data Presented at European Society of Cardiology Congress
5. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
6. Kuvan Receives Positive Opinion From CHMP for European Approval
7. Pharmaxis Research Programs Highlighted at European Respiratory Society Congress
8. Elseviers PharmaPendium(TM) Adds European Medicines Agency (EMEA) Documents
9. European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia
10. PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress
11. Oslo and Toulouse Cancer Clusters Join Forces to Drive European Cancer Research Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO of ... Rotary Club. The event entitled “Stem Cells and Their Regenerative Powers,” ... Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
Breaking Biology Technology:
(Date:4/11/2017)... BEACH GARDENS, Fla. , April 11, 2017 ... identity management and secure authentication solutions, today announced ... contract by Intelligence Advanced Research Projects Activity (IARPA) ... for IARPA,s Thor program. "Innovation has ... onset and IARPA,s Thor program will allow us ...
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
Breaking Biology News(10 mins):